Fachliteratur Gastroenterologie: Neoplasien Pankreas

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Pankreas » Neoplasie

11. Juni 2026

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 3018


	Artikel 1 - 20 / 60358

	Chinese expert consensus on conversion and perioperative therapy of primary liver cancer (2024 edition). Hepatobiliary Surg Nutr Wang Z, Sun H, Zhou J, Xie Q, Bi X, Liu X, Liu R, Zhao M, Bai X, Ji Y, Xu L, Jia W, Zeng S, Li G, Zhang W, Shen S, Rao S, Shi G, Zhang L, Zhu X, Wu Z, Wang J, Tang H, Bai D, Chen Y, Chen Y, Dai C, Gu F, Guo J, Guo R, Guo W, Han F, Han G, Hao C, Huang T, Huang X, Huang Y, Huang Z, Jiao S, Li D, Li T, Li X, Li G, Liang P, Liang X, Lin J, Liu F, Liu J, Liu J, Lu Z, Lv W, Mao Y, Meng Z, Peng C, Peng L, Peng T, Shi M, Shi Y, Song T, Tan G, Tang Y, Tao K, Wan C, Wang G, Wang K, Wang L, Wang M, Wang S, Wang W, Wen T, Xiang B, Xing B, Xu J, Xu J, Yan S, Yang D, Yang J, Yin G, Yu Z, Zeng Y, Zhang J, Zhang S, Zhang T, Zhang Y, Zhang Y, Zhang Y, Zhang Z, Zhang A, Zhao H, Zhao H, Zhou L, Zhou W, Zhu Z, Qin S, Shen F, Cai X, Cai J, Chen M, Li Q, Liu L, Wang W, Liang T, Zhang B, Lu S, Cheng S, Ren Z, Wu H, Kuang M, Teng G, Dou K, Dong J, Chen X, Wang X, Zheng S, Fan J, Alliance of Liver Cancer Conversion Therapy, Liver Cancer Committee, China Anti-Cancer Association. PMID: 42273581 [PubMed]
	Prediction of postoperative early recurrence and response to adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma with microvascular invasion after hepatectomy: a multicenter study. Hepatobiliary Surg Nutr Zhang TC, Li ZQ, Jia WL, Cao Y, Hu MG, Wang K, Xu S, Jiang T, Lin C, Chen X, Tan G, Xia NX, Zhao WC, Yan ML, Xu YF, Tan XD, Zhang F, Wang X, Tang YF, Ni QQ, Hu YL, Cheng SQ, Zhang XP, Liu R. PMID: 42273570 [PubMed]
	Metabolic Dysfunction-associated Steatotic Liver Disease Diminishes the Efficacy of miR-125b-5p-engineered MSC Therapy for Hepatocellular Carcinoma via HK2 Upregulation: A Multimodal Theranostic Study. J Clin Transl Hepatol Shen L, Luo X, Su X, Zhou X, Zou F, Zhong S, Deng Y, Yin B, Yao Z, Guo R. PMID: 42273383 [PubMed]
	A prediction tool for malnutrition and sarcopenia in patients with gastroenteropancreatic neuroendocrine neoplasms: results from NUTRIGETNE (GETNE-S2109) study. Front Nutr Argente-Pla M, Sampedro-Nuñez MA, Garcia-Carbonero R, Custodio A, Hernando J, Suarez L, Hernandez-Rienda L, Peiró I, Alonso V, Serrano R, Valdés N, Melian M, Febrero B, Biarnes J, Díaz-Pérez JÁ, Molina-Cerrillo J, Lopez C, Martínez Olmos MÁ, Merino-Torres JF, Capdevila J, Del Olmo-García M, NUTRIGETNE GROUP. PMID: 42272908 [PubMed]
	Opioid-Sparing Effect of Celiac Plexus Neurolysis in Palliative Care Patients with Upper Abdominal Cancer: A Single-Center Retrospective Case Series of Thirteen Patients. J Hosp Palliat Care Kim DH, Kim YA, Ha TH, Kwak SG. PMID: 42272642 [PubMed]
	Real-World Evidence on the Efficacy of Icaritin for Unresectable Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Study. Int J Cancer Zhang D, Xie Q, Zhang Z, Wang S, Liu J, An X, Liu K, Yu Z, Xiang H, He Q, Zheng X, Chang Z, Du R, Zhang L, Li G, Xu Q, Song W, Jin B, Liu C, Li J, Zhou X, Li W, Yang X, Zhang C, Zeng H. PMID: 42272432 [PubMed - as supplied by publisher]
	The phase I trial of preoperative short-course chemoradiotherapy with S-1/irinotecan and short-course radiation in locally advanced lower rectal cancer (SHOWTIME study). Radiat Oncol Kojo K, Tanaka T, Yamanashi T, Miura H, Yokoi K, Kojima K, Yokota K, Kawakami S, Ishiyama H, Yamashita K, Kumamoto Y, Hiki N, Sato T, Naitoh T. PMID: 42271445 [PubMed - as supplied by publisher]
	Combination of paricalcitol with chemotherapy shows promise in phase 1 study of metastatic pancreatic cancer. Nat Cancer PMID: 42270903 [PubMed - as supplied by publisher]
	Sarcopenia modifies the survival benefit of triple therapy versus TACE alone in elderly patients with unresectable hepatocellular carcinoma: A multicenter retrospective cohort study. Sci Rep Ye L, Yue W, Lin K, Liao J, Mo A, Liu G, Chen X, Shi H, Wang T, Mo Q, Weng J, Zhou Y, Li R, Jiang Z, Luo J, Huang B, Yu Y. PMID: 42270819 [PubMed - as supplied by publisher]
	Effects of Chemotherapy on Survival Outcomes in Older Patients with Metastatic Pancreatic Cancer: A Nationwide Population-Based Study. Gut Liver Son K, Park BK, Park CS, Han JH, Lee KJ. PMID: 42270328 [PubMed - as supplied by publisher]
	A phase II clinical trial of albumin-bound paclitaxel, cisplatin, gemcitabine (NABPLAGEM) and paricalcitol as neoadjuvant therapy in pancreatic cancer. Oncologist Viniotis AF, Jameson GS, Wertheim BC, Roe DJ, Lee K, Tsai FY, Gordon MS, Sharma S, Guarnieri CM, Snyder CE, Thosani AJ, Amini A, Sckolnik SE, Garrick JM, Korn RL, Rahmanuddin S, Evans RM, Downes M, Truitt M, Von Hoff DD, Borazanci EH. PMID: 42268676 [PubMed - as supplied by publisher]
	Oxidative balance score, genetic susceptibility, and the risk of pancreatic cancer: a population-based cohort study. Nutr J Liu Y, Liu P, Cui D, Ji X, Li W, Li Y, Zhao Y, Tan X, Xia Y. PMID: 42265737 [PubMed - as supplied by publisher]
	Robotic Surgery for Pancreas Cancer. Surg Oncol Clin N Am Underwood PW, Dillhoff M. PMID: 42264697 [PubMed - indexed for MEDLINE]
	Pancreatic Neuroendocrine Neoplasms. Semin Ultrasound CT MR Panda A, Itani M, Mhlanga J, Singh C, Catalano OA, Lall C, Arif-Tiwari H, Chu L. PMID: 42264416 [PubMed - as supplied by publisher]
	Laparoscopic versus open pancreaticoduodenectomy in patients with periampullary carcinoma: A randomised clinical trial. J Minim Access Surg Chauhan V, Sharma A, Nag HH, Shetty A, Saluja SS, Sachdeva S, Chandra S, Sakhuja P. PMID: 42262773 [PubMed - as supplied by publisher]
	Integrative machine learning and multi-omics analysis reveals ATIC as a promoter of hepatocellular carcinoma progression. Sci Rep Xie L, Wang T, Pan C, Lan J, Yang Y, Lv L, Zhou C, Qin S, Ning Y. PMID: 42259854 [PubMed - as supplied by publisher]
	More harm than good? The UK National Screening Committee's latest review of prostate cancer screening. BJU Int Boshari T, Anderson A, Richards M. PMID: 42259762 [PubMed - as supplied by publisher]
	The atlas of abdominal organ remodeling in hepatocellular carcinoma patients: An artificial intelligence-based multicenter imaging study. Med Guo Y, Fu X, Li T, Wang N, Jiang S, Li S, Guo X, Wang R, Long S, Li M, Liu Q, Zhao K, Xie Y, Chen X, Wang L, Zheng C, Yang L. PMID: 42259298 [PubMed - as supplied by publisher]
	Association between postoperative Clostridioides difficile infection and outcomes following pancreatoduodenectomy for pancreatic cancer: a national cohort study. Surg Endosc Daniel F, Abdallah B, Chaitou AR, Makki M, Mrad R, Khalife M, Tamim H. PMID: 42257924 [PubMed - in process]
	Sequential alternation of nal-IRI/5-FU and gemcitabine/nab-paclitaxel versus nal-IRI/5-FU versus gemcitabine/nab-paclitaxel in first-line metastatic pancreatic cancer: results of the randomized phase II PRODIGE 61-FUNGEMAX trial (France). EClinicalMedicine Taieb J, Pernot S, Thuillier F, Delattre A, Vo-Quang E, Petorin C, Bourgeois V, Tougeron D, Audemar F, Vitellius C, Mosser L, Desrame J, Di Fiore F, Rinaldi Y, Pellat A, Bolliet M, Watelle F, Perrier H, Dubreuil O, Lepage C, Bachet JB. PMID: 42256682 [PubMed]

Artikel 1 - 20 / 60358

Seite 1 von 3018



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung